Superworth

Warby Parker price to sales ratio WRBY

Market value divided by revenue over the last twelve months, since 2022.

Today, Nov 2, 2026
3.2×
4-year median
2.9×
Against its 4-year history
63rd
percentile: 0 is its lowest day, 100 its highest
4-year range
1.8× to 4.5×
Peer median
3.3×

Warby Parker's price to sales ratio is 3.2× as of Nov 2, 2026.

That is above its 4-year median of 2.9×, close to the middle of its last 4 years.

Over that time it ranged from 1.8× in Nov 2023 to 4.5× in Jan 2025.

The median for 10 medical instruments and supplies stocks of a similar size is 3.3×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far3.2×2.8×4.1×
20253.5×2.2×4.5×
20244.0×2.1×4.1×
20232.5×1.8×3.3×
20222.7×2.5×3.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Warby Parker's size, closest first, today.

CompanyPrice to sales ratio
WRBYWarby Parker3.2×
ATRCAtriCure5.3×
UFPTUFP Technologies3.5×
NVSTEnvista1.4×
ICUIICU Medical1.9×
INSPInspire Medical Systems2.2×
BMIBadger Meter5.1×
LMATLemaitre Vascular7.1×
VNTVontier1.6×
MMSIMerit Medical Systems3.1×
HAEHaemonetics4.0×
Peer median3.3×

Where Warby Parker ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Warby Parker

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.